Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Robert L Ferris George R Blumenschein Everett E Vokes Naomi Kiyota Maura L. Gillison |
| Publication date | June 23, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |